CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes.
about
Anti-PEG immunity: emergence, characteristics, and unaddressed questions.Polymersome-based drug-delivery strategies for cancer therapeuticsRecent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingStealth nanoparticles: high density but sheddable PEG is a key for tumor targeting.Effect of surface properties on liposomal siRNA delivery.DNA nanocarriers for systemic administration: characterization and in vivo bioimaging in healthy micePEGylation as a strategy for improving nanoparticle-based drug and gene deliveryUnderstanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.Clinical developments in nanotechnology for cancer therapy.Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.Towards effective non-viral gene delivery vector.Side-chain cysteine-functionalized poly(2-oxazoline)s for multiple peptide conjugation by native chemical ligation.Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform.Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility.Activation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production.Poly(2-oxazoline)s as materials for biomedical applications.Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood-brain barrier and enhance doxorubicin antiglioma effect.Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.
P2860
Q26825556-FAF17212-E6ED-406C-B16A-462B9027C753Q28083454-2C9797A4-E98E-4858-A3C4-81C953DA799AQ30456053-B193A9E5-2C55-42BA-B8D7-7F55F6159BDDQ33987573-DE2F1957-2D1C-4C16-9DC5-72E7F6425E0AQ36421379-52DF4DEF-FDD4-4379-B6AA-31C828FBB5E9Q36587584-291A8800-0442-458D-8A87-403AA54710E0Q36703361-9A260FB6-3172-49EF-A327-3EF7C9E7F319Q36739647-208AEADB-0A3B-4063-9629-A5DDD148ADA8Q37765187-B5945B8B-6432-4D86-A75B-B8D772B7A5AEQ38648908-432934B3-DA3E-48AA-AA29-49DE8C92AD0BQ38830057-3C732DB7-35BF-4F3D-964B-4E0ACB090E10Q38904846-C1B2C4BB-FF64-49CD-B172-70B262454D3FQ39197452-5A9E7E1B-6BD5-43D3-8CB2-3F85BE4479EEQ39339434-488405EE-C6E2-4290-BA3B-86E920D6163EQ42227407-8706CF85-0244-416D-B543-21B62FECDF76Q45856157-701DF834-684F-4AFD-945E-24A29B114CA0Q47175638-51B850DB-C0AA-4AF5-AC81-79793FB62AA5Q53662280-3F12FCFB-5428-41A5-A1FC-37BEAA1E5CA6
P2860
CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
CpG motifs in pDNA-sequences i ...... by PEG-coated pDNA-lipoplexes.
@en
CpG motifs in pDNA-sequences i ...... by PEG-coated pDNA-lipoplexes.
@nl
type
label
CpG motifs in pDNA-sequences i ...... by PEG-coated pDNA-lipoplexes.
@en
CpG motifs in pDNA-sequences i ...... by PEG-coated pDNA-lipoplexes.
@nl
prefLabel
CpG motifs in pDNA-sequences i ...... by PEG-coated pDNA-lipoplexes.
@en
CpG motifs in pDNA-sequences i ...... by PEG-coated pDNA-lipoplexes.
@nl
P2093
P1476
CpG motifs in pDNA-sequences i ...... by PEG-coated pDNA-lipoplexes.
@en
P2093
Hiroshi Kiwada
Kazuya Nakamura
Naoshi Yamazaki
Taro Shimizu
Tatsuaki Tagami
Tatsuhiro Ishida
P304
P356
10.1016/J.JCONREL.2009.10.017
P407
P577
2009-10-20T00:00:00Z